glp-1 treatment for pre-diabetes Medications | Fact Sheets Navigating GLP-1 use in therapy
Description
The LSD post-hoc test for the interaction revealed that LIR was associated with cumulative METH intake from the second day of the treatment (day 16, p = 0.011) till the end of the study (day 17, p = 0.005
Research is ongoing about the link between these meds and mental health
Circulating endogenous GLP-1 has a half-life of 12 min, being rapidly inactivated by dipeptidyl-peptidase IV
#semaglutide #obesity #novonordisk #pharmasales Heres the free BioNucleus Briefing newsletter Twice-weekly biotech news, drama, and context
economy up to $1.72 trillion annually
However, GLP-1 possesses broader pharmacological effects including anti-inflammation, neuro-protection, regulating blood pressure (BP), and reducing lipotoxicity
